FNDC5 and obesity due to melanocortin 4 receptor deficiency: Despite differences in methodology to quantify irisin concentrations, systemic irisin levels are increased in obesity which may reduce the potential of using irisin as a therapeutic agent, although levels are likely decreased in T2DM (144).